Lipid nanoparticle-mediated drug delivery to the brain

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777

Engineering precision nanoparticles for drug delivery

Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028

The blood-brain barrier

Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312

Toxicity of cationic lipids and cationic polymers in gene delivery

Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286

The blood–brain barrier: an overview

Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276

Progress and challenges towards targeted delivery of cancer therapeutics

Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220

Phenotypic Heterogeneity of the Endothelium

Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,824

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822

Biological Activity of Ionic Liquids and Their Application in Pharmaceutics and Medicine

Egorova, K. S., Gordeev, E. G., & Ananikov, V. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00562 · Cited by 1,698

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609

Receptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor System

Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russell, D. W., & Schneider, W. J. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.000245 · Cited by 1,600

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

Culver, K. W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E. H., & Blaese, R. M. (1992) · Science · doi:10.1126/science.1317968 · Cited by 1,506

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261

Challenges in Development of Nanoparticle-Based Therapeutics

Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173

Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic

Puri, A., Loomis, K. H., Smith, B. J., Lee, J. H., Yavlovich, A., Heldman, E., & Blumenthal, R. P. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,099

RNAi therapeutics: a potential new class of pharmaceutical drugs

Bumcrot, D. A., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,097

Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages

Mohammadi‐Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 975

Lipid-like materials for low-dose, in vivo gene silencing

Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969

Current Strategies for Brain Drug Delivery

Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954

A Neurovascular Niche for Neurogenesis after Stroke

Ohab, J. J., Fleming, S., Blesch, A., & Carmichael, S. T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4323-06.2006 · Cited by 878

mRNA-based therapeutics: powerful and versatile tools to combat diseases

Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 852

The function of α-synuclein

Bendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825

Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN

Hinderer, C., Katz, N., Buza, E. L., Dyer, C., Goode, T., Bell, P., Richman, L. K., & Wilson, J. M. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.015 · Cited by 814

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801

Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 796

Evaluation of intranasal delivery route of drug administration for brain targeting

Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 773

Application of liposomes in medicine and drug delivery

Daraee, H., Etemadi, A., Kouhi, M., Alimirzalu, S., & Akbarzadeh, A. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.953633 · Cited by 767

Monocarboxylate transporters in the central nervous system: distribution, regulation and function

Pierre, K., & Pellerin, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03168.x · Cited by 744

A Comprehensive Review on Current Advances in Peptide Drug Development and Design

Lee, A. C.-L., Harris, J. L., Khanna, K. K., & Hong, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102383 · Cited by 706

Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke

Knowland, D., Arac, A., Sekiguchi, K. J., Hsu, M., Lutz, S. E., Perrino, J., Steinberg, G. K., Barres, B. A., Nimmerjahn, A., & Agalliu, D. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.003 · Cited by 703

Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA

Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685

On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA

Kulkarni, J. A., Darjuan, M. M., Mercer, J. E., Chen, S., van der Meel, R., Thewalt, J. L., Tam, Y. Y. C., & Cullis, P. R. (2018) · ACS Nano · doi:10.1021/acsnano.8b01516 · Cited by 663

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y. L., McGarrity, G. J., Muul, L. M., et al. (1997) · Nature Medicine · doi:10.1038/nm1297-1354 · Cited by 661

Brain Function and Blood Flow

Lassen, N. A., Ingvar, D. H., & Skinhöj, E. (1978) · Scientific American · doi:10.1038/scientificamerican1078-62 · Cited by 640

Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study

Collaborators, G. 2. U. N. D., Feigin, V. L., Vos, T., Alahdab, F., Amit, A. M. L., Bärnighausen, T. W., Beghi, E., Beheshti, M., Chavan, P. P., Criqui, M. H., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4152 · Cited by 622

Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., Fenton, O. S., Zhang, Y., Olejnik, K. T., Yesilyurt, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5277 · Cited by 615

Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing

Wei, T., Cheng, Q., Min, Y.-L., Olson, E. N., & Siegwart, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-17029-3 · Cited by 615

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., Schubert, M. S., Friedmann-Morvinski, D., Cohen, Z. R., Behlke, M. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc9450 · Cited by 614

Lipid nanoparticles enabling gene therapies: from concepts to clinical utility

Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592

Receptor-mediated endocytosis

Wileman, T. E., Harding, C., & Stahl, P. D. (1985) · Biochemical Journal · doi:10.1042/bj2320001 · Cited by 566

Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation

Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124407 · Cited by 561

α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Kontopoulos, E., Parvin, J. D., & Feany, M. Β. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl243 · Cited by 553

Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation

Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549

Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles

Yanez Arteta, M., Kjellman, T., Bartesaghi, S., Wallin, S., Wu, X., Kvist, A. J., Dabkowska, A., Székely, N., Radulescu, A., Bergenholtz, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720542115 · Cited by 534

Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery

Chauhan, I., Yasir, M., Verma, M., & Singh, A. P. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.021 · Cited by 527

The dose threshold for nanoparticle tumour delivery

Ouyang, B., Poon, W., Zhang, Y.-N., Lin, Z. P., Kingston, B. R., Tavares, A. J., Zhang, Y., Chen, J., Valic, M. S., Syed, A. M., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-0755-z · Cited by 524

Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis

Qiu, M., Tang, Y., Chen, J., Muriph, R. E., Ye, Z., Huang, C., Evans, J. J., Henske, E. P., & Xu, Q. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116271119 · Cited by 514

Receptor-mediated endocytosis: insights from the lipoprotein receptor system

Brown, M. S., & Goldstein, J. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3330 · Cited by 506

Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates

Gray, S. J., Matagne, V., Bachaboina, L., Yadav, S., Ojeda, S. R., & Samulski, R. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.72 · Cited by 501

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

Nault, J.-C., Datta, S., Imbeaud, S., Franconi, A., Mallet, M., Couchy, G., Letouzé, E., Pilati, C., Verret, B., Blanc, J.-F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3389 · Cited by 489

Microstructural and Dynamical Heterogeneities in Ionic Liquids

Wang, Y., Li, B., Sarman, S., Mocci, F., Lu, Z., Yuan, J., Laaksonen, A., & Fayer, M. D. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00693 · Cited by 478

Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration

Carrasco, M. J., Alishetty, S., Alameh, M., Said, H., Wright, L., Paige, M. A., Soliman, O. Y., Weissman, D., Cleveland, T. E., Grishaev, A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02441-2 · Cited by 460

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454

Rapid endothelial cytoskeletal reorganization enables early blood–brain barrier disruption and long-term ischaemic reperfusion brain injury

Shi, Y., Zhang, L., Pu, H., Mao, L., Hu, X., Jiang, X., Xu, N., Stetler, R. A., Zhang, F., Liu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms10523 · Cited by 431

Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells

Filion, M. C., & Phillips, N. C. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00126-0 · Cited by 428

Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors

Gray, S. J., Foti, S. B., Schwartz, J. W., Bachaboina, L., Taylor-Blake, B., Coleman, J., Ehlers, M. D., Zylka, M. J., McCown, T. J., & Samulski, R. J. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.245 · Cited by 420

The age factor in Alzheimer’s disease

Guerreiro, R., & Bras, J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0232-5 · Cited by 415

Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease

Roney, C. A., Kulkarni, P. V., Arora, V., Antich, P. P., Bonte, F. J., Wu, A., Mallikarjuana, N. N., Manohar, S. K., Liang, H., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 411

Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

Gray, M. T., & Woulfe, J. M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.32 · Cited by 409

Role of Monocarboxylate Transporters in Drug Delivery to the Brain

Vijay, N., & Morris, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990462 · Cited by 408

Impact of particle elasticity on particle-based drug delivery systems

Anselmo, A. C., & Mitragotri, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.007 · Cited by 392

AAV serotype 2 vectors preferentially integrate into active genes in mice

Nakai, H., Montini, E., Fuess, S., Storm, T. A., Grompe, M., & Kay, M. A. (2003) · Nature Genetics · doi:10.1038/ng1179 · Cited by 392

Long range electrostatic forces in ionic liquids

Gebbie, M. A., Smith, A. M., Dobbs, H. A., Lee, A. A., Warr, G. G., Banquy, X., Valtiner, M., Rutland, M. W., Israelachvili, J. N., Perkin, S., et al. (2016) · Chemical Communications · doi:10.1039/c6cc08820a · Cited by 389

Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles

Schlich, M., Palomba, R., Costabile, G., Mizrahy, S., Pannuzzo, M., Peer, D., & Decuzzi, P. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10213 · Cited by 387

Lactoferrin

Baker, E. N., & Baker, H. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5368-9 · Cited by 387

Ionic liquids for oral insulin delivery

Banerjee, A., Ibsen, K. N., Brown, T. D., Chen, R., Agatemor, C., & Mitragotri, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722338115 · Cited by 379

Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates

Gray, S. J., Nagabhushan Kalburgi, S., McCown, T. J., & Jude Samulski, R. (2013) · Gene Therapy · doi:10.1038/gt.2012.101 · Cited by 377

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

Brenner, J. S., Pan, D. C., Myerson, J. W., Marcos-Contreras, O. A., Villa, C. H., Patel, P., Hekierski, H., Chatterjee, S., Tao, J.-Q., Parhiz, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05079-7 · Cited by 363

Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease

Agrawal, M., Ajazuddin, Tripathi, D. K., Saraf, S., Saraf, S., Antimisiaris, S. G., Mourtas, S., Hammarlund-Udenaes, M., & Alexander, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.019 · Cited by 356

Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease

Gao, H.-M., Zhang, F., Zhou, H., Kam, W., Wilson, B., & Hong, J.-S. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003013 · Cited by 355

Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization

Zakrewsky, M., Lovejoy, K. S., Kern, T. L., Miller, T. E., Le, V., Nagy, A., Goumas, A. M., Iyer, R. S., Sesto, R. E. D., Koppisch, A. T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403995111 · Cited by 354

Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model11Published on the World Wide Web on 10 October 2000.

Björklund, A., Kirik, D., Rosenblad, C., Georgievska, B., Lundberg, C., & Mandel, R. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02915-2 · Cited by 349

Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core

Leung, A. K. K., Hafez, I. M., Baoukina, S., Belliveau, N. M., Zhigaltsev, I. V., Afshinmanesh, E., Tieleman, D. P., Hansen, C., Hope, M. J., & Cullis, P. (2012) · The journal of physical chemistry. C, Nanomaterials and interfaces · doi:10.1021/jp303267y · Cited by 339

State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery

Evers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M. (2018) · Small Methods · doi:10.1002/smtd.201700375 · Cited by 332

Mitochondria in Ischemic Stroke: New Insight and Implications

Liu, F., Lu, J., Manaenko, A., Tang, J., & Hu, Q. (2018) · Aging and Disease · doi:10.14336/ad.2017.1126 · Cited by 332

Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems

Maeki, M., Kimura, N., Sato, Y., Harashima, H., & Tokeshi, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.008 · Cited by 329

Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns

Göppert, T. M., & Müller, R. H. (2005) · Journal of drug targeting · doi:10.1080/10611860500071292 · Cited by 299

Improved Anti-Tumor Effect of Liposomal Doxorubicin After Targeted Blood-Brain Barrier Disruption by MRI-Guided Focused Ultrasound in Rat Glioma

Treat, L. H., McDannold, N. J., Zhang, Y., Vykhodtseva, N. I., & Hynynen, K. (2012) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2012.04.015 · Cited by 296

Viral vectors for gene delivery to the central nervous system

Lentz, T. B., Gray, S. J., & Samulski, R. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.014 · Cited by 295

Recent Advances in Ionic Liquids in Biomedicine

Curreri, A. M., Mitragotri, S., & Tanner, E. E. L. (2021) · Advanced Science · doi:10.1002/advs.202004819 · Cited by 291

Cancer nanotechnology: current status and perspectives

Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 290

Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease

Hu, K., Shi, Y., Jiang, W., Han, J., Huang, S., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.062 · Cited by 272

Nonbilayer phase of lipoplex–membrane mixture determines endosomal escape of genetic cargo and transfection efficiency

Zuhorn, I. S., Bakowsky, U., Polushkin, E., Visser, W. H., Stuart, M. C. A., Engberts, J. B. F. N., & Hoekstra, D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.018 · Cited by 268

Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma

Johnsen, K. B., Burkhart, A., Melander, F., Kempen, P. J., Vejlebo, J. B., Siupka, P., Nielsen, M. S., Andresen, T. L., & Moos, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11220-1 · Cited by 268

Lactate Transport and Signaling in the Brain: Potential Therapeutic Targets and Roles in Body—Brain Interaction

Bergersen, L. H. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.206 · Cited by 266

Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model

Wagner, S., Zensi, A., Wien, S., Tschickardt, S., Maier, W., Vogel, T., Worek, F., Pietrzik, C. U., Kreuter, J., & von Briesen, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032568 · Cited by 265

CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells

Min, Y.-L., Li, H. Z., Rodríguez-Caycedo, C., Mireault, A. A., Huang, J. H., Shelton, J. M., McAnally, J., Amoasii, L., Mammen, P. P. A., Bassel‐Duby, R., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav4324 · Cited by 262

Transdermal insulin delivery using choline-based ionic liquids (CAGE)

Tanner, E. E. L., Ibsen, K. N., & Mitragotri, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.029 · Cited by 261

Anion Exchanger 1 (Band 3) Is Required to Prevent Erythrocyte Membrane Surface Loss but Not to Form the Membrane Skeleton

Peters, L. L., Shivdasani, R. A., Liu, S., Hanspal, M., John, K. M., Gonzalez, J. M., Brugnara, C., Gwynn, B., Mohandas, N., Alper, S. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80167-1 · Cited by 259

Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders

Schaser, A. J., Osterberg, V. R., Dent, S. E., Stackhouse, T. L., Wakeham, C. M., Boutros, S. W., Weston, L. J., Owen, N., Weissman, T. A., Luna, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47227-z · Cited by 256

“You Shall Not Pass”—tight junctions of the blood brain barrier

Bauer, H., Krizbai, I. A., Bauer, H., & Traweger, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00392 · Cited by 255

Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons

Guo, S., Kim, W. J., Lok, J., Lee, S.-R., Besancon, E., Luo, B.-H., Stins, M. F., Wang, X., Dedhar, S., & Lo, E. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801105105 · Cited by 253

Transdermal Protein Delivery Using Choline and Geranate (CAGE) Deep Eutectic Solvent

Banerjee, A., Ibsen, K. N., Iwao, Y., Zakrewsky, M., & Mitragotri, S. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601411 · Cited by 249

Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA

Kulkarni, J. A., Myhre, J. L., Chen, S., Tam, Y. Y. C., Danescu, A., Richman, J. M., & Cullis, P. R. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.12.014 · Cited by 243

Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy

Zhang, D., Wang, G., Yu, X., Wei, T., Farbiak, L., Johnson, L. T., Taylor, A. M., Xu, J., Hong, Y., Zhu, H., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01122-3 · Cited by 243

In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery

Jose, S., Anju, S. S., Cinu, T. A., Aleykutty, N., Thomas, S., & Souto, E. B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.003 · Cited by 241

Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model

Virtanen, J. A., Cheng, K. H., & Somerharju, P. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4964 · Cited by 240

What are lipoproteins doing in the brain?

Wang, H., & Eckel, R. H. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.10.003 · Cited by 234

Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy

Kumar, V., Qin, J., Jiang, Y., Duncan, R. G., Brigham, B., Fishman, S., Nair, J. K., Akinc, A., Barros, S. A., & Kasperkovitz, P. V. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.61 · Cited by 222

Band 3, the human red cell chloride/bicarbonate anion exchanger (AE1, SLC4A1), in a structural context

Reithmeier, R. A. F., Casey, J. R., Kalli, A. C., Sansom, M. S. P., Alguel, Y., & Iwata, S. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.03.030 · Cited by 222

Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection

Ma, F., Yang, L., Sun, Z., Chen, J., Rui, X., Glass, Z., & Xu, Q. (2020) · Science Advances · doi:10.1126/sciadv.abb4429 · Cited by 218

Exploiting Endocytosis for NanomedicinesPreprint

Akinc, A., & Battaglia, G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016980 · Cited by 215

Relationship Between Amyloid-β Deposition and Blood–Brain Barrier Dysfunction in Alzheimer’s Disease

Wang, D., Chen, F., Han, Z., Yin, Z., Ge, X., & Lei, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.695479 · Cited by 208

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA

Blakney, A. K., McKay, P. F., Yus, B. I., Aldon, Y., & Shattock, R. J. (2019) · Gene Therapy · doi:10.1038/s41434-019-0095-2 · Cited by 206

Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier

Doll, D. N., Hu, H., Sun, J., Lewis, S. E., Simpkins, J. W., & Ren, X. (2015) · Stroke · doi:10.1161/strokeaha.115.009099 · Cited by 202

Monocarboxylate transport in erythrocytes

Deüticke, B. (1982) · The Journal of Membrane Biology · doi:10.1007/bf01870219 · Cited by 201

The Threshold Theory for Parkinson's Disease

Engelender, S., & Ole Isacson, A. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.008 · Cited by 196

Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells

D’souza, A. A., Burch, A. M., Dave, K. M., Sreeram, A., Reynolds, M. J., Dobbins, D. X., Kamte, Y. S., Zhao, W., Sabatelle, C., Joy, G. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.038 · Cited by 194

Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain

Gupta, Y., Jain, A., & Jain, S. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.7.0004 · Cited by 193

Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth

Zelepukin, I. V., Yaremenko, A. V., Shipunova, V. O., Babenyshev, A., Balalaeva, I. V., Nikitin, P. I., Deyev, S. M., & Nikitin, M. P. (2018) · Nanoscale · doi:10.1039/c8nr07730d · Cited by 189

Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor

Hsu, S., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 185

Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons

Makita, T., Sucov, H. M., Gariepy, C. E., Yanagisawa, M., & Ginty, D. D. (2008) · Nature · doi:10.1038/nature06859 · Cited by 185

Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier

Banks, W. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.005 · Cited by 184

Lipid Based Vesicular Drug Delivery Systems

Jain, S., Jain, V., & Mahajan, S. C. (2014) · Advances in Pharmaceutics · doi:10.1155/2014/574673 · Cited by 183

Localized RNAi Therapeutics of Chemoresistant Grade IV Glioma Using Hyaluronan-Grafted Lipid-Based Nanoparticles

Cohen, Z. R., Ramishetti, S., Peshes-Yaloz, N., Goldsmith, M., Wohl, A., Zibly, Z., & Peer, D. (2015) · ACS Nano · doi:10.1021/nn506248s · Cited by 182

Effect of Nanoparticle Composition, Size, Shape, and Stiffness on Penetration Across the Blood–Brain Barrier

Brown, T. D., Habibi, N., Wu, D., Lahann, J., & Mitragotri, S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00743 · Cited by 182

Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells

Basha, G., Novobrantseva, T. I., Rosin, N. L., Tam, Y. Y. C., Hafez, I. M., Wong, M., Sugo, T., Ruda, V. M., Qin, J., Klebanov, B., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.190 · Cited by 182

Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers

Maeki, M., Fujishima, Y., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187962 · Cited by 182

Correlation of the cytotoxic effects of cationic lipids with their headgroups

Cui, S., Wang, Y., Gong, Y., Lin, X., Zhao, Y., Zhi, D., Zhou, Q., & Zhang, S. (2018) · Toxicology Research · doi:10.1039/c8tx00005k · Cited by 180

Acute Direct Adenoviral Vector Cytotoxicity and Chronic, but Not Acute, Inflammatory Responses Correlate with Decreased Vector-Mediated Transgene Expression in the Brain

Thomas, C. E., Birkett, D., Anozie, I., Castro, M. G., & Lowenstein, P. R. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0224 · Cited by 173

Characterization of Cytoplasmic α-Synuclein Aggregates

Lee, H.-J., & Lee, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208192200 · Cited by 172

ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier

Magro, R. D., Ornaghi, F., Cambianica, I., Beretta, S., Re, F., Musicanti, C., Rigolio, R., Donzelli, E., Canta, A., Ballarini, E., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.039 · Cited by 168

Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma

Zhang, P., Miska, J. M., Lee-Chang, C., Rashidi, A., Panek, W. K., An, S., Ζαννίκου, Μ., Lopez‐Rosas, A., Han, Y., Xiao, T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906346116 · Cited by 166

Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain

Rungta, R. L., Choi, H. B., Lin, P. J., Ko, R. W., Ashby, D., Nair, J., Manoharan, M., Cullis, P. R., & MacVicar, B. A. (2013) · Molecular Therapy—Nucleic Acids · doi:10.1038/mtna.2013.65 · Cited by 165

Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)

Kumari, S., Saad, M. A., Kumar, J. M., Kondapi, A. K., & Rao, N. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06888-4 · Cited by 164

Mechanism of Antibacterial Activity of Choline-Based Ionic Liquids (CAGE)

Ibsen, K. N., Ma, H., Banerjee, A., Tanner, E. E. L., Nangia, S., & Mitragotri, S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00486 · Cited by 161

Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels

Cunha, S., Forbes, B., Lobo, J. M. S., & Silva, A. C. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s305851 · Cited by 157

Comparison of Adeno-Associated Viral Vector Serotypes for Spinal Cord and Motor Neuron Gene Delivery

Snyder, B. R., Gray, S. J., Quach, E. T., Huang, J. W., Leung, C. H., Samulski, R. J., Boulis, N. M., & Federici, T. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.008 · Cited by 156

Endothelium-targeted overexpression of heat shock protein 27 ameliorates blood–brain barrier disruption after ischemic brain injury

Shi, Y., Jiang, X., Zhang, L., Pu, H., Hu, X., Zhang, W., Cai, W., Gao, Y., Leak, R. K., Keep, R. F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621174114 · Cited by 153

Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis

Zhao, Z., Ukidve, A., Gao, Y., Kim, J., & Mitragotri, S. (2019) · Science Advances · doi:10.1126/sciadv.aax9250 · Cited by 152

ApoE Deficiency Compromises the Blood Brain Barrier Especially After Injury

Methia, N., André, P., Hafezi-Moghadam, A., Economopoulos, M., Thomas, K. L., & Wagner, D. D. (2001) · Molecular Medicine · doi:10.1007/bf03401973 · Cited by 150

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**

Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie · doi:10.1002/ange.201203263 · Cited by 150

Consideration for the scale‐up manufacture of nanotherapeutics—A critical step for technology transfer

Liu, X., & Meng, H. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200190 · Cited by 144

Modulation of Membrane Fusion by Asymmetric Transbilayer Distributions of Amino Lipids

Bailey, A. L., & Cullis, P. R. (1994) · Biochemistry · doi:10.1021/bi00208a007 · Cited by 143

A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System

Wu, D., Qin, M., Xu, D., Wang, L., Liu, C., Ren, J., Zhou, G. W., Chen, C., Yang, F., Li, Y., et al. (2019) · Advanced Materials · doi:10.1002/adma.201807557 · Cited by 140

Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia

Nabhan, J. F., Wood, K. M., Rao, V. P., Morin, J., Bhamidipaty, S., LaBranche, T. P., Gooch, R. L., Bozal, F., Bulawa, C. E., & Guild, B. C. (2016) · Scientific Reports · doi:10.1038/srep20019 · Cited by 140

Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers

Brenner, J. S., Mitragotri, S., & Muzykantov, V. R. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-121219-024239 · Cited by 138

Tumor targeting of functionalized lipid nanoparticles: Assessment by in vivo fluorescence imaging

Goutayer, M., Dufort, S., Josserand, V., Royère, A., Heinrich, E., Vinet, F., Bibette, J., Coll, J., & Texier, I. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.007 · Cited by 135

The Neurovascular Unit in Glaucomatous Neurodegeneration

Wareham, L. K., & Calkins, D. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00452 · Cited by 134

Discovery of a Novel Amino Lipid That Improves Lipid Nanoparticle Performance through Specific Interactions with mRNA

Cornebise, M., Narayanan, E., Xia, Y., Acosta, E. P., Ci, L., Koch, H., Milton, J., Sabnis, S., Salerno, T., & Benenato, K. E. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106727 · Cited by 134

ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood–Brain Barrier

Topal, G. R., Mészáros, M., Porkoláb, G., Szecskó, A., Polgár, T. F., Siklós, L., Deli, M. A., Veszelka, S., & Bozkır, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010038 · Cited by 133

Perfection of a synaptic receptor: kinetics and energetics of the acetylcholine receptor.

Jackson, M. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2199 · Cited by 133

Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation

Elabi, O. F., Gaceb, A., Carlsson, R., Padel, T., Soylu-Kucharz, R., Cortijo, I., Li, W., Li, J., & Paul, G. (2021) · Scientific Reports · doi:10.1038/s41598-020-80889-8 · Cited by 131

Nanoparticle‐Based Therapeutics for Brain Injury

Bharadwaj, V. N., Nguyen, D. T., Kodibagkar, V. D., & Stabenfeldt, S. E. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700668 · Cited by 130

Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function

Ukidve, A., Zhao, Z., Fehnel, A., Krishnan, V., Pan, D. C., Gao, Y., Mandal, A., Muzykantov, V. R., & Mitragotri, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002880117 · Cited by 128

Regulation of cellular ATP release.

Fitz, J. (2007) · PubMed · Cited by 126

Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery

Shi, B., Keough, E., Matter, A., Leander, K., Young, S., Carlini, E., Sachs, A. B., Tao, W., Abrams, M., Howell, B., et al. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411410885 · Cited by 125

Liposomes as targetable drug carriers.

Torchilin, V. P. (1985) · PubMed · Cited by 125

Ionic liquid-mediated delivery of insulin to buccal mucosa

Vaidya, A., & Mitragotri, S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.037 · Cited by 125

Targeting the blood-brain barrier for the delivery of stroke therapies

D’souza, A. A., Dave, K. M., Stetler, R. A., & Manickam, D. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.015 · Cited by 125

Mechanistic study of transdermal delivery of macromolecules assisted by ionic liquids

Qi, Q. M., & Mitragotri, S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.029 · Cited by 124

Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E

Neves, A. R., Queiroz, J. F., Weksler, B., Romero, I. A., Couraud, P.-O., & Reis, S. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/49/495103 · Cited by 122

Monocarboxylic acid transporters, MCT1 and MCT2, in cortical astrocytes in vitro and in vivo

Hanu, R., McKenna, M. C., O’Neill, A., Resneck, W. G., & Bloch, R. J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.5.c921 · Cited by 114

Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways

Neves, A. R., Queiroz, J. F., Lima, S. A. C., & Reis, S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00705 · Cited by 113

Liposomes as delivery agents for medical imaging

Torchilin, V. P. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88805-8 · Cited by 109

Transdermal delivery of nobiletin using ionic liquids

Hattori, T., Tagawa, H., Inai, M., Kan, T., Kimura, S.-I., Itai, S., Mitragotri, S., & Iwao, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-56731-1 · Cited by 109

The Blood–Brain Barrier in Alzheimer's Disease

Sharma, H. S., Castellani, R. J., Smith, M. A., & Sharma, A. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00003-x · Cited by 105

Crosstalk between cerebral endothelium and oligodendrocyte

Miyamoto, N., Pham, L. D., Seo, J. H., Kim, K., Lo, E. H., & Arai, K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1488-9 · Cited by 105

Ionic Liquids Induced Structural Changes of Bovine Serum Albumin in Aqueous Media: A Detailed Physicochemical and Spectroscopic Study

Singh, T., Bharmoria, P., Morikawa, M., Kimizuka, N., & Kumar, A. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp303609h · Cited by 105

Apicobasal polarity of brain endothelial cells

Worzfeld, T., & Schwaninger, M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15608644 · Cited by 104

Poststroke Induction of -Synuclein Mediates Ischemic Brain Damage

Kim, T., Mehta, S. L., Kaimal, B., Lyons, K. E., Dempsey, R. J., & Vemuganti, R. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1241-16.2016 · Cited by 104

Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA

Lin, P. J. C., Tam, Y. Y. C., Hafez, I. M., Sandhu, A. P., Chen, S., Ciufolini, M. A., Nabi, I. R., & Cullis, P. R. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.019 · Cited by 101

The dissociation of acetylcholine from open nicotinic receptor channels

Grosman, C. F., & Auerbach, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251402498 · Cited by 100

A Novel Purification Method for CNS Projection Neurons Leads to the Identification of Brain Vascular Cells as a Source of Trophic Support for Corticospinal Motor Neurons

Dugas, J. C., Mandemakers, W. J., Rogers, M., Ibrahim, A., Daneman, R., & Barres, B. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2010-08.2008 · Cited by 99

Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood–brain barrier and glioma cells

Andresen, T. L., Bruun, J., Larsen, T. B., Jølck, R. I., Eliasen, R., Holm, R., & Gjetting, T. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87334 · Cited by 98

Ionization Behavior of Amino Lipids for siRNA Delivery: Determination of Ionization Constants, SAR, and the Impact of Lipid pKa on Cationic Lipid−Biomembrane Interactions

Zhang, J., Fan, H., Levorse, D. A., & Crocker, L. S. (2011) · Langmuir · doi:10.1021/la104590k · Cited by 96

Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein

Davies, N. M., Hovdal, D., Edmunds, N. J., Nordberg, P., Dahlén, A., Dabkowska, A. P., Arteta, M. Y., Rădulescu, A., Kjellman, T., Höijer, A., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.03.008 · Cited by 93

Complications associated with intrathecal drug delivery systems

Delhaas, E. M., & Huygen, F. J. P. M. (2019) · BJA Education · doi:10.1016/j.bjae.2019.11.002 · Cited by 93

Transferrin-functionalized lipid nanoparticles for curcumin brain delivery

Neves, A. R., van der Putten, L., Queiroz, J. F., Pinheiro, M., & Reis, S. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.03.010 · Cited by 92

Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles

Morse, S. V., Mishra, A., Chan, T. G., de Rosales, R. T. M., & Choi, J. J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.005 · Cited by 90

Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme

Jnaidi, R., Almeida, A. J., & Gonçalves, L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090860 · Cited by 89

Apolipoprotein E, Amyloid-β, and Blood-Brain Barrier Permeability in Alzheimer Disease

Donahue, J. E., & Johanson, C. E. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a0dc8 · Cited by 87

Functional Expression of Choline Transporters in the Blood–Brain Barrier

Inazu, M. (2019) · Nutrients · doi:10.3390/nu11102265 · Cited by 86

Cross-linked antioxidant nanozymes for improved delivery to CNS

Klyachko, N. L., Manickam, D. S., Brynskikh, A. M., Uglanova, S. V., Li, S., Higginbotham, S. M., Bronich, T. K., Batrakova, E. V., & Kabanov, A. V. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.010 · Cited by 84

The blood-brain barrier choline transporter as a brain drug delivery vector

Allen, D. D., & Lockman, P. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00504-6 · Cited by 83

Drug Delivery Systems for Imaging and Therapy of Parkinson';s Disease

Silindir‐Gunay, M., Özer, A. Y., & Chalon, S. (2015) · Current Neuropharmacology · doi:10.2174/1570159x14666151230124904 · Cited by 83

Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice

Liu, M., Kuhel, D. G., Shen, L., Hui, D. Y., & Woods, S. C. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00219.2012 · Cited by 82

Localized viral vector delivery to enhance in situ regenerative gene therapy

Hu, W., Wang, Z., Hollister, S. J., & Krebsbach, P. H. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302940 · Cited by 78

Protein and mRNA Delivery Enabled by Cholesteryl‐Based Biodegradable Lipidoid Nanoparticles

Li, Y., Jarvis, R., Zhu, K., Glass, Z., Ogurlu, R., Gao, P., Li, P., Chen, J., Yu, Y., Yang, Y., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004994 · Cited by 75

Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors

Puhl, D. L., D’Amato, A. R., & Gilbert, R. J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.05.024 · Cited by 74

Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity

Emami, J., Yousefian, H., & Sadeghi, H. (2018) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30117 · Cited by 70

Cell physiology and molecular mechanism of anion transport by erythrocyte band 3/AE1

Jennings, M. L. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00275.2021 · Cited by 69

Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery

van der Meel, R., Chen, S., Zaifman, J., Kulkarni, J. A., Zhang, X. R. S., Tam, Y. K., Bally, M. B., Schiffelers, R. M., Ciufolini, M. A., Cullis, P. R., et al. (2021) · Small · doi:10.1002/smll.202103025 · Cited by 69

Extracellular ATP Released by Osteoblasts Is A Key Local Inhibitor of Bone Mineralisation

Orriss, I. R., Key, M. L., Hajjawi, M. O. R., & Arnett, T. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069057 · Cited by 68

The generation and function of soluble apoE receptors in the CNS

Rebeck, G. W., LaDu, M. J., Estus, S., Bu, G., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-15 · Cited by 66

Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting

Shobaki, N., Sato, Y., & Harashima, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s188016 · Cited by 65

Protein-avoidant ionic liquid (PAIL)–coated nanoparticles to increase bloodstream circulation and drive biodistribution

Hamadani, C. M., Goetz, M. J., Mitragotri, S., & Tanner, E. E. L. (2020) · Science Advances · doi:10.1126/sciadv.abd7563 · Cited by 64

Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy

Nakamura, K., Mori, F., Kon, T., Tanji, K., Miki, Y., Tomiyama, M., Kurotaki, H., Toyoshima, Y., Kakita, A., Takahashi, H., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0208-0 · Cited by 61

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

Wang, J., Ding, Y., Chong, K. C., Cui, M., Cao, Z., Tang, C., Tian, Z., Hu, Y., Zhao, Y., & Jiang, S. (2024) · Vaccines · doi:10.3390/vaccines12101148 · Cited by 270

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

Shi, Y., Shi, M., Wáng, Y., & You, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02002-z · Cited by 243

Ionic liquids revolutionizing biomedicine: recent advances and emerging opportunities

Hu, Y., Xing, Y., Yue, H., Chen, T., Diao, Y., Wei, W., & Zhang, S. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00510k · Cited by 149

SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors

Sun, Q., Xing, X., Wang, H., Wan, K., Fan, R., Liu, C., Wang, Y., Wu, W., Wang, Y., & Wang, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115586 · Cited by 125

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity

Wu, L., Li, X., Qian, X., Wang, S., Liu, J., & Yan, J. (2024) · Vaccines · doi:10.3390/vaccines12020186 · Cited by 137

Brain delivery of lipid nanoparticles with shuttle peptides

Martínez-Martínez, N., CARRERA-RODRÍGUEZ, L., Vargas, R., Hernández-Munaín, C., Suñé-Pou, M., & Suñé, C. M. I. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.02.005 · Cited by 1

Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer

Cai, X., Drummond, C. J., Zhai, J., & Tran, N. L. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202404234 · Cited by 75

role of lipid based nanoparticles in brain targeted drug delivery system

Kumar, K. P., Nihal, P. M., Bandari, N., Iswariya, V. T., Rao, A. H. O. P., Rana, R., & Kaushik, S. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.8628 · Cited by 2

Lipid nanoparticles functionalization strategies to cross the blood-brain-barrier.

Vargas, R., Narváez-Narváez, D. A., Moreno‐Castro, C., Nardi-Ricart, A., Peréz-Lozano, P., García-Montoya, E., Suñé-Negre, J. M., Hernández-Munaín, C., Suñé, C., & Suñé-Pou, M. (2022) · DIGITAL.CSIC (Spanish National Research Council (CSIC))

High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain

Han, E. L., Kim, D., Murray, A. M., Mrksich, K., Hamilton, A. G., Tang, S., Yoo, S., Zhu, A. T., Tong, E. R., Palanki, R., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c19138 · Cited by 5